TSE:CCT - Catamaran Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeC$44.17 - C$80.46
VolumeN/A
Average Volume775,784 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Catamaran logoCatamaran Corporation (Catamaran) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company operates in two segments: PBM and HCIT. The Company offers PBM services, which are marketed under the Catamaran PBM brand, and is engaged in owning and operating a network of mail and specialty pharmacies. In addition, the Company is a national provider of drug benefits to its customers under the federal government's Medicare Part D program. The Company's HCIT product offerings include a range of software products for managing prescription drug programs and for drug prescribing and dispensing. The Company's customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third-party healthcare plan administrators, and state and federal government entities.

Receive CCT News and Ratings via Email

Sign-up to receive the latest news and ratings for CCT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange TSE
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolTSE:CCT
CUSIPN/A
Phone+1-800-2823232

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins1.66%
Return on Equity6.54%
Return on Assets4.25%

Miscellaneous

EmployeesN/A
Outstanding Shares208,010,000
Market CapC$0.00

Catamaran (TSE:CCT) Frequently Asked Questions

What is Catamaran's stock symbol?

Catamaran trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CCT."

What is the consensus analysts' recommendation for Catamaran?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Catamaran in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Has Catamaran been receiving favorable news coverage?

Press coverage about CCT stock has trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Catamaran earned a daily sentiment score of 0.18 on Accern's scale. They also assigned media coverage about the company an impact score of 45.10 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.

How do I buy shares of Catamaran?

Shares of CCT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How can I contact Catamaran?

Catamaran's mailing address is 1600 McConnor Pkwy, SCHAUMBURG, IL 60173-6801, United States. The company can be reached via phone at +1-800-2823232.


MarketBeat Community Rating for Catamaran (TSE CCT)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  75 (Vote Outperform)
Underperform Votes:  79 (Vote Underperform)
Total Votes:  154
MarketBeat's community ratings are surveys of what our community members think about Catamaran and other stocks. Vote "Outperform" if you believe CCT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CCT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.